Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02120469
Title Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center

triple-receptor negative breast cancer


Eribulin + Everolimus

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center Duarte California 91010 United States Details
City of Hope Rancho Cucamonga Rancho Cucamonga California 91730 United States Details
South Pasadena Cancer Center South Pasadena California 91030 United States Details
*Shaded cells indicate that there was no data available from for the field